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ABSTRACT
Background: Adult T-cell Leukemia (ATL) is a disease with no known cure. The disease manifests itself as an
aggressive proliferation of CD4+ cells with the human T-cell Lymphotropic virus type 1 (HTLV-1). The
leukemogenesis of the virus is mainly attributed to the viral oncoprotein. Tax activates the Nuclear Factor kappa B
(NF-B) which stimulates the activity and expression of the matrix metalloproteinase-9 (MMP-9). The objective of
this study was to investigate the efficacy of a specific nutrient synergy (SNS) on proliferation, Tax expression, NF-B
levels as well as on MMP-9 activity and expression both at the transcriptional and translational levels in two HTLV-1
positive cell lines, HuT-102 and C91-PL at 48h and 96h of incubation. Cytotoxicity of Epigallocatechin-3-gallate
(EGCG) was assayed using CytoTox 96 Non-radioactive and proliferation was measured using Cell Titer96TM
Nonradioactive Cell Proliferation kit (MTT- based assay). Enzyme linked immunosorbant assay (ELISA) and
electrophoretic mobility shift assay (EMSA) were used to assess the effect of SNS on NF-B mobility. Zymography
was used to determine the effects of SNS on the activity and secretion of MMP-9. The expression of MMP-9 was
done using RT-PCR at the translational level and Immunoblotting at the transcriptional level.
Results: A significant inhibition of proliferation was seen in both cell lines starting at a concentration of 200μg/ml
and in a dose dependent manner. SNS induced a dose dependent decrease in Tax expression, which was
paralleled by a down-regulation of the nuclearization of NF-B. This culminated in the inhibition of the activity of
MMP-9 and their expression both at the transcriptional and translational levels.
Conclusions: The results of this study indicate that a specific nutrient synergy targeted multiple levels pertinent to
the progression of ATL. Its activity was mediated through the NF-B pathway, and hence has the potential to be
integrated in the treatment of this disease as a natural potent anticancer agent.
Background
The human T-cell lymphotropic virus type 1 (HTLV1) is
a retrovirus that infects CD4-positive T-cells resulting in
the development of adult T-cell leukemia (ATL) in
approximately 5% of the cases. ATL manifests as a conse-
quence of the clonal expansion of mature and activated
infected CD-4 positive T-cells and is associated with a
poor prognosis due to its immunosuppressive and che-
motherapy-resistant nature [1]. The causative agent of
this disease, HTLV1, is transmitted via breast feeding,
transplacentally from mother to child, through sexual
contact and blood transfusion [2]; while in vivo transmis-
sion occurs through cell-to-cell contact [3]. The HTLV1
oncoprotein, Tax, has been shown to be vital for viral
persistence and leukemogenesis due to its pleitoropic
effects on cellular proliferation and apoptosis as well as
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viral replication [4]. As such, targeting Tax has become a
novel approach in the treatment of ATL; however, the
current options either failed to nullify the issue of relapse
[5]. Therefore, it is essential to unravel a nontoxic com-
pound having an inherent ability to inhibit Tax expres-
sion and a potential to serve as a therapeutic agent
against this aggressive malignancy.
The successful documentation of the safety and effec-
tiveness of botanical and dietary natural compounds in
cancer prevention has led to the development of a nutrient
mixture composed of ascorbic acid (AA), lysine, proline,
arginine, epigallocatechingallate (EGCG) and other micro-
nutrients [6]. This natural assortment of nutrients, also
known as SNS has exhibited synergistic anticancer proper-
ties in a large number of solid cancer cell lines, blocking
tumor growth, tumor invasion and MMP expression, both
in vitro and in vivo [7]. Not only that, but SNS had an
anti-proliferative effect against HTVL-1 positive and nega-
tive malignant T-lymphocytes and demonstrated pro-
apoptotic effects with respect to HTLV-1 leukemic cells in
specific, via the up-regulation of the pro-apoptotic pro-
teins p53, p21 and Bax, and the down-regulation of the
pro-survival Bcl2-a protein [8]. We have also reported
enhanced antiproliferative activity of SNS in the presence
of polyethylene glycol gold plated nano-particles [9].
SNS was in fact formulated based on the capacity of the
individual components to alter key physiological path-
ways involved in cancer progression and metastasis [10].
In fact, ingredients of SNS were reported to inhibit the
destruction of the extracellular matrix (ECM), which is a
pre-requisite for cancer cell invasion and metastasis [11].
For example, the biosynthesis of collagen depends on an
adequate supply of AA, the amino acids lysine and pro-
line as well as the micronutrients manganese and copper
[12]. Therefore, the integration of these nutrients into
the formulation would result in strengthening the ECM.
Not only that, but lysine is also a natural inhibitor of
plasmin-induced proteolysis and, therefore, increases
ECM stability by inhibiting the breakdown of collagen
fibers [11]. Similarly, N-acetyl cysteine, AA, selenium and
EGCG inhibited the invasiveness of tumor cells by block-
ing the activity of MMPs, which are a unique family of
more than 20 proteases responsible for the proteolytic
degradation of the ECM, which is essential for the disse-
mination of cancer cells to secondary sites [12]. The
over-expression of MMPs, which is a common occur-
rence in malignant tumors, is correlated with tumor
aggressiveness, stage and prognosis [11,12].
Additionally, multiple studies have associated the
makeup of SNS with inhibitory activity against the tran-
scription factor NF- B, which is constitutively activated
by HTLV-1 Tax protein and has as a critical role in the
pathophysiology of ATL [13]. In fact, the inhibitory effect
of EGCG on the activity of NF-kB has recently been
demonstrated in ATL cell lines [14]. With respect to AA,
it was able to dose-dependently repress activation of
NFB [Harakeh et al., unpublished data]. Furthermore,
N-acetyl-cysteine (NAC) was found to reverse NF-B
binding to DNA and NF-B-dependent oncogene expres-
sion in HaCaT cells [15]; while selenium compounds
were capable of preventing esophageal carcinogenesis by
inhibiting NF-kB activation [16]. Finally, magnesium defi-
ciency induced NFB expression in endothelial [17] and
macrophage cells [18]. Nonetheless, the synergistic effect
of the nutrient mixture on NF-kB activity in HTLV1
infected cells is yet to be determined.
The combination of these micronutrients is accompa-
nied by the advantage of using lower doses of the sepa-
rate constituents and has the potential of increasing the
biological effect by establishing novel metabolic targets
[6]. Therefore the objective of this study is to investigate
the efficacy of SNS on Tax expression, NF-B levels as
well as on MMP-9 activity and expression both at the
transcriptional and translational levels in two HTLV-1
positive cell lines, HuT-102 and C91-PL thus determin-
ing the potential of using SNS in conjunction to
ongoing treatment.
Results and discussion
Effect of non-cytotoxic concentrations of SNS on
proliferation
To identify the doses to be used in subsequent experi-
ments, we determined the range of non-cytotoxic con-
centrations of SNS against the C91-PL and HuT-102
HTLV1- positive cell lines used. Cells were grown in the
presence of various concentrations of SNS ranging from
0 to 1000μg/ml. Concerning the effects of such doses on
freshly activated human mononuclear lymphocytes, it
was previously shown that the concentrations used in
this study had no pronounced toxicity [8].
There was a dose-dependent decline in the viable cell
counts in the case of both two cell lines tested. The
dose which resulted in the death of 50% of the cells was
recorded (D50) (Figure 1A, C). The corresponding
reduction in proliferation at D50 was also documented
for the two cell lines (Figure 1B, D). For C91-PL cell
line, the D50 was 772 and 365µg/ml at 48h and 96h of
exposure respectively (Figure 1B) and was associated to
a high anti-proliferative effect (p < 0.05) of 82% and
65% after 48h versus 96h in comparison to the control
(Figure 1A). Similarly, the D50 HuT-102 cell line were
respectively 586 and 500 µg/ml at 48h and 96h. A sig-
nificant decrease in proliferation activity at these two
aforementioned culture periods was respectively of 62%
and 91% when compared to the control (Figure 1B).
The potent inhibitory concentrations of proliferation
(<500μg/ml) found in this study were within the pre-
viously reported range of concentrations [9]. Moreover,
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while studies using solid cancer cell lines indicated an
anti-proliferative effect in the first 24 hrs of treatment
[6], this effect was observed in our cell lines starting at
48h to become more pronounced at 96h of treatment in
the two cell lines (Figure 1). In fact, upon treating the
cell lines with tested concentrations for 24h, there were
no observed effects in either one of the two cell lines
(Data not shown). The same lag was also observed upon
treating the cells with EGCG [14,19] and AA [unpub-
lished results, [20]]. This might indicate a requirement
of the cells to undergo a few cycles of replications in
the presence of the test compound for it to start exert-
ing an effect.
Therefore in all the experiments that followed, where
the incubation period was increased to 96h, only the
non-cytotoxic concentrations of SNS (200-350 μg/ml)
were applied to the two cell lines. Those concentrations
were non-cytotoxic in primary cultures of freshly iso-
lated normal human T-lymphocytes (Data not shown).
Effect of SNS on Tax expression
Tax is 40 kDa phosphoprotein encoded by the pX
region of the HTLV1 genome. It is a viral protein post-
translationally modified by ubiquitination, phosphoryla-
tion and acetylation, which enable this oncoprotein to
affect a plethora of cellular processes that work together
to promote the survival and proliferation of infected
cells [3]. The effect of SNS on viral proteins in general
has not been investigated; however EGCG has been
documented to suppress HTLV-I pX mRNA [21]; while
treating HPV transfected HeLa cells with vitamin C
down-regulated the protein expression of the viral onco-
protein E6 [22]. Moreover, these two major constituents
of SNS induced a dose dependent decrease in Tax
expression [[14], unpublished results].
The effect of SNS on the viral oncoprotein, Tax
expression was studied by western blotting and GAPDH
was used to ensure equal protein loading (Figure 2).
The results revealed that SNS induced a dose dependent
decrease on Tax translational expression levels in both
HTLV-I positive cell lines (Figure 2). For the same con-
centration of 200μg/ml SNS showed more potency in
reducing Tax protein levels in the C91-PL cell line com-
pared to the HuT-102 cell line. However in both cell
lines Tax expression was almost completely lost at a
concentration of 350μg/ml.
Figure 1 Cytotoxicity and anti-proliferative effects of SNS. Effect of SNS on cytotoxicity (A, C) and proliferation (B, D) of C91-PL and HuT-102
HTLV-1 positive cell lines respectively. Each value is the mean ± SD of three separate experiments done in triplicates.
Figure 2 Effects of SNS on Tax expression in C91-PL and HuT-102
cell lines. GAPDH was used as a control. The immunoblots
represent results obtained in three independent replicates.
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Effects of SNS on NF-B activity
Tax has been shown to immortalize cells in vitro and to
promote tumor formation in transgenic mice [3]. This is
correlated with its intrinsic ability to alter the expression
of a number of cellular genes by acting on multiple sig-
naling pathways, the most prominent of which is NF-B.
The transcriptional factor NF-B is rendered constitu-
tively active by Tax in HTLV1-infected cells [3]. The
constitutive activation of NF-B by Tax due to the Tax’s
ability to override this inhibitory mechanism by activat-
ing inhibitor of nuclear factor kappa-B kinase (IKK) or
inducing the proteosomal degradation of the inhibitor of
nuclear factor kappa-B (IkB). Moreover Tax acted in the
nucleus either directly or indirectly to promote the inter-
action of the p65 subunit with coactivators that are
necessary for its transcriptional activity [13].
To establish the effect of SNS on NF-B activity, we
used EMSA to identify the dimer combination of this
transcription factor present in the nucleus. The results
revealed that both HuT-102 and C91-PL harbored the
p65/p50 heterodimer in their nuclei (data not shown).
Nuclear extracts obtained from both cell lines were
then subjected to ELISA, in order to quantitatively eval-
uate the impact of SNS on the relocation one of the het-
erodimer proteins p65 from the cytoplasm to the
nucleus. The results showed that the test compound
induced a dose dependent decrease in the nuclear levels
of p65; where the inhibition was greater in C91-PL cells,
reaching around 82%, and to a lesser extent in HuT-102
cells, reaching 75%. These reductions were obtained at
the highest applied concentrations of SNS in both cell
lines (Figure 3A, B).
It appears that SNS concurrently induced a dose
dependent decrease in the binding of the p65/p50
heterodimer to its DNA consensus sequence in the
C91-PL cell line (Figure 3C); in addition to the HuT-
102 cell line (Data not shown). The binding specificity
of p65 to NF-B consensus probe was determined using
mutant and cold probes (Data not shown).
The effects of the test compound on NF-B may be
indirect and due to its inhibitory effect on Tax which
would be expected to inhibit the Tax induced constitu-
tive activation of NF-B by reversing the aforemen-
tioned mechanisms of action. Even though, there has
not been any study that we know of linking SNS with
NF-kB, there is overwhelming evidence correlating a
number of its constituents with the expression and
activity of this transcription factor. In fact EGCG, vita-
min C and selenium inhibited the activation of NF-B
by blocking the activity of IKK [23,24]. Moreover,
EGCG suppressed the activity of NF-B in HeLa cervi-
cal cancer cells through the inhibition of phosphoryla-
tion and consequent degradation of IBa and IBb [25].
Similarly AA inhibited the degradation of IBa in
human acute myeloid leukemia HL-60 cell lines [26].
Another constituent, NAC, suppressed the expression of
NF-kB mediated proliferation genes, such as c-FLIP,
Cyclin D and Bcl2 through the inhibition of IKK activity
[27]. Therefore the inhibitory effect induced by SNS on
NF-B activity might be occurring indirectly, as a conse-
quence of SNS’s effect on Tax expression or it might be
due to the direct synergistic effect of the its various
components on regulatory elements involved in the acti-
vation of this transcription factor.
Effect of SNS on MMP-9 expression at the transcriptional
level
MMPs are extracellular proteases that have been shown to
favor cancer invasion and metastasis by ameliorating the
infiltration of tumor cells from the primary site to secondary
organs. The gelatinase MMP-9 has been especially corre-
lated with the infiltration and metastasis of leukemia cells;
where it has been reported, both in vitro and in vivo, that
high MMP-9 expression levels are associated with clinically
aggressive tumors and worse prognosis of non-Hodgkin’s
lymphomas (NHL) [28]. Moreover, it has been suggested
that the invasiveness of ATL can be at least in part attribu-
ted to the over-expression of MMP9 in HTLV-1 positive
cells [29].
To investigate the effect of SNS on the transcriptional
level of MMP-9, mRNA isolated from C91-PL and HuT-
102 cells treated with non-cytotoxic concentrations of the
test compound were exposed to RT-PCR which amplified
and quantified their respective MMP-9 mRNA levels. The
PCR products were then subjected to agarose gel electro-
phoresis. The results indicated that SNS induced a dose
dependent decrease in MMP-9 mRNA levels in both cell
lines and that this inhibitory effect started at a
Figure 3 Effects of SNS on NF-B activity and nuclear translocation
in HuT-102 and C91-PL HTLV-1 positive cell lines. (A, B) Nuclear
quantity of NF-B assessed by ELISA done in triplicate. (C) EMSA gel
is a representative of three independent experiments with nuclear
C91-PL extract.
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concentration of 200μg/ml of SNS (Figure 4A). Note that
ribosomal phosphorprotein was used to ensure equal
loading.
The results indicated that SNS down-regulated the
mRNA expression levels of MMP-9 in a dose dependent
manner starting at a concentration of 200μg/ml. The
MMP-9 promoter harbors several putative NF-B con-
sensus sequences making this protease a target gene for
the NF-B transcription factor [29]. Accordingly, it is
hypothesized that the SNS-induced reduction of MMP-9
transcription in the HTLV-1 infected cells was at least
in part due to its inhibition of the NF-B nuclear trans-
location and activity. In fact, a major constituent of
SNS, EGCG, inhibited MMP-9 expression at the tran-
scriptional level through the inactivation of NF-B via
the inhibition of PI3K/AKT activation in T24 human
bladder cancer cells [30]. Similarly, it hampered MMP-2
and MMP-9 transcription in human prostate carcinoma
DU-145 cells by inhibiting the activation of C-Jun and
NF-B transcription factors and the phosphorylation of
p38 and ERK1/2 pathways [31]. Moreover, EGCG inhib-
ited the EGF induced DNA binding activity of NF-B to
the MMP9 promoter and down-regulated the resulting
expression and gelatinolytic activity of MMP9 in MDA-
MB-231 human breast cancer cell line [32], while it modu-
lated MMP9 expression by preventing the nuclear deloca-
lization of NF-B in lung carcinoma 95-D cells [33].
Moreover, EGCG was also reported to inhibit the EGF
induced DNA binding activity of NF-B to the MMP9
promoter and to down-regulate the resulting expression
and gelatinolytic activity of MMP9 in MDA-MB-231
human breast cancer cell line [32]. In lung carcinoma 95-
D cells, EGCG modulated MMP9 expression by prevent-
ing the nuclear delocalization of NF-B [33]
Effect of SNS on MMP-9 expression at the translational
level
In general, there is no correlation between mRNA levels
and their subsequent protein levels. In fact MMP-9 is
known as a mRNA that having a highly structured 5’UTR
rendering its translation dependent on the activity of the
eukaryotic initiation factor 4E (eIF-4E). The latter being
the rate-limiting and mRNA cap binding component of
the eukaryotic initiation factor 4F (eIF-4F) translation
initiation complex. In general, there is no correlation
between mRNA levels and their subsequent protein
levels. In fact, MMP-9 is considered a weak mRNA hav-
ing a highly structured 5’UTR rendering its translation
dependent on the activity of the eIF-4E. Nonetheless, a
number of SNS constituents decreased the protein
expression levels of this gelatinase independently from
their activity on mRNA level [[14], Harakeh S unpub-
lished data].
To further inspect the effect of the test compound on
the concentration needed to affect MMP-9 protein
levels, western blotting was used. Cells were incubated
with various concentrations of SNS for 96h. The protein
levels of MMP-9 were subsequently determined using
Figure 4 Effects of SNS on MMP-9 expression and activity. Effect of SNS on MMP-9 mRNA (A), protein (B) and activity (C) in two ATL-HTLV-1
positive cell lines. Equal loading was ensured using ribosomal protein for mRNA expression (A) and GAPDH for protein expression (B).The
experiments were done in triplicates.
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specific antibodies. SNS clearly induced a dose depen-
dent decrease in the translational levels of MMP-9 in
both cell lines starting at a concentration of 200μg/ml
(Figure 4B). Therefore, the translational levels of MMP9
seem to be equal to the transcriptional levels of its
mRNA in their susceptibility to SNS (Figure 4A). To
ensure equal protein loading, the GADPH was used.
Effect of SNS on MMP-9 activity
MMPs are synthesized as inactive pro-enzymes [34] and
their proteolytic activity is regulated by a well-organized
pathway, which includes the conversion of plasminogen
to plasmin that is crucial for MMP activation [9]. To
evaluate the effect of SNS on MMP9’s activity, which cor-
relates with the invasion potential of the two cell lines,
zymography was used. As shown in Figure 4C, the test
compound induced a dose dependent decrease in the
activity of MMP-9 in both cell lines, also starting at
200μg/ml. This decrease seems to culminate in an almost
complete inhibition of MMP-9’s gelatine degrading
potential at 350μg/ml; which was especially obvious in
the C91-PL cell line (Figure 4C).
In fact the lysine present in SNS is a natural inhibitor of
plasmin-induced proteolysis and therefore might interfere
with the activity of MMP-9 at this level. Moreover, lysine
[9], AA (unpublished) and EGCG [14] inhibited MMP9
activity in a dose dependent manner in HTLV1 infected
malignant T-cells. In addition, L-arginine decreased the
activity of MMP-2 and MMP-9 in mdx muscle fibers [35]
and in an isolated lung perfusion rat model of acute pul-
monary embolism (APE) [36]. In addition, the supplemen-
tation of cord plasma and HUVEC line with physiological
doses of magnesium sulfate led to the attenuation of
MMP-9 activity [37]. Therefore, the SNS induced decrease
in MMP-9 activity is in accordance with the previously
published effect of its separate constituents.
Conclusions
The results of this study showed for the first time that
SNS induces a dose dependent inhibition of Tax expres-
sion, NF-B activity as well as MMP9 activity and expres-
sion both at the transcriptional and translational levels
starting at a concentration of 200μM in the two HTLV1
infected cell lines. Therefore, it seems that SNS targets
multiple levels pertinent to the progression of ATL and
hence has the potential to be integrated in the treatment
of this disease as a natural, yet potent anticancer agent.
Materials and methods
SNS composition
1mg/ml of SNS solution contains 900 µM of ascorbate,
1.1 mM of lysine, 1.1 mM of proline, 500 µM of arginine,
250 µM of N-acetylcysteine, 150 µM of EGCG, 85 µM of
Selenium, 7 µM of copper and 4 µM of manganese and
4 µM Calcium. Each SNS, whose source was reported
earlier [8], was dissolved in RPMI 1640 media in stock
solutions of 33.3 mg/ml, filter-sterilized using a 0.22µm
filter, aliquoted and stored at -20°C until the day of the
experiment. Each stored aliquot was used for just one
experiment only and the left over was discarded.
Cell lines
Two HTLV-1 positive ATL cell lines were used, namely
HuT-102 and C91-PL (provided by Dr A. Gessain, Institut
Pasteur Paris, France). The cells were grown in RPMI
1640 complete growth media with 25 mM of Hepes, sup-
plemented with 10% Fetal Bovine Serum, 100 µg/ml of
Streptomycin and 100 U/ml of Penicillin. Cells were routi-
nely grown at 37°C in a 5% CO2-humidified incubator.
Cell growth and cytotoxicity
Cytotoxicity of SNS at different concentrations was
assayed using CytoTox 96 Non-radioactive Cytotoxicity
Assay (Promega, Corp., Madison, WI) and proliferation
was measured using Cell Titer96TM Nonradioactive Cell
Proliferation kit (Promega Corp., Madison, WI). Experi-
ments were carried out according to the instructions of
the manufacturer and as prescribed previously [38,39].
ELISA and EMSA for NF-B
The HTLV-1 positive cell lines were grown in the pre-
sence or absence of the test compound and harvested at
the end of the experiment and nuclear extracts were
obtained as previously described [14]. Protein concentra-
tions were determined using the Bio-Rad DC Protein
Assay Kit (BioRad Laboratories, Hercules, CA), with inclu-
sion of bovine serum albumin as a standard. For the
ELISA, the 96-well plate, supplied with the kit (Roche,
Mannheim, Germany), was coated with anti-p65 antibody
(Santa Cruz Biotechnology Inc., Santa Cruz, CA), and the
procedure was followed according to the manufacturer’s
instructions. For EMSA, NF-B consensus oligonucleo-
tides and mutant sequences (see Table 1) were end-labeled
with g-32P ATP, using T4-polynucleotide kinase, and the
assay was performed as described previously [14].
RT- PCR for MMP-9 mRNA expression
Both cells treated or untreated for 96h with the test
compound were collected and stored at -80°C. Total
RNA was extracted from the cells using NucleoSpin
RNA II kit (Macherey, Nagel). After testing different
RNA concentrations and assessed their quality control,
two micrograms of mRNA were reverse transcribed into
first strand cDNA using One Step RT-PCR kit (Ready
Mix Version) (Abgene, Promega). Reactions was con-
ducted in 50µl volume using specific oligonucleotide
primers designed to detect MMP-9 and ribosomal phos-
phoprotein according to conditions shown in Table 1.
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Ribosomal phosphoprotein (NCBI: NM_022402.2) was
used to ensure equal loading.
Western Blotting for MMP-9 and Tax proteins expression
The HTLV-1-positive cells treated or not with test com-
pound were lysed in a buffer containing 50mM Tris–
HCl, pH 7.5, 150mM NaCl, 1% Nonidet P40, 0.5%
sodium deoxycholate, 4% protease inhibitors, and 1%
phosphatase inhibitors. Western blotting was conducted
as prescribed previously [14]. The Primary antibodies
specific to MMP-9, Tax, and GAPDH were obtained
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA)
and horseradish peroxidase-conjugated secondary anti-
body were purchased from (Bio-Rad, Hercules,CA). The
detection procedure of the protein bands was performed
using an enhanced chemiluminescence system, and
banded proteins were developed on X-Ray film using a
Xomat machine (Amersham, Pharmacia, Biotech).
Zymography for MMP-9 activity
Cells were treated with various concentrations of SNS
for three days and then starved, by removing the FBS
from the growth medium, for 24 hours and treating the
cells with various concentrations of the test compound.
The zymography experiments were performed as pre-
viously described [14].
Statistical analysis
The one-way analysis of variance (ANOVA) was used in
data analysis. The discrepancies between the means of
both treated and untreated control groups were tested for
significance using Fisher’s least significant differences at
p≤0.05 (Fisher PLSD). An effect was considered significant
when the value (±) of mean difference between groups
exceeded Fisher PLSD in the one factor ANOVA test.
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